INS and Glucose intolerance: In ArKO mice, estrogens' role in hepatic glucose intolerance may be explained by its ability to significantly reduce key hepatic insulin signaling genes G6Pase and PEPCK upon E2 administration, which we observed by 3 months of age and continued through to 6 months of age.